Prospective Data Sources Sample Clauses

Prospective Data Sources. In this section, we will present the measures selected to be recorded during the prospective pilot and the workflow captured in D1.3 for transferring data from Noona that will capture these data to the BOUNCE data infrastructure. Standardized scales and questionnaires to be used in the prospective pilot study are listed below • Ten item Personality measure (brief Big Five) • PTSD Checklist • Life Orientation Test Revised • Sense of Coherence scale • The Perceived Ability to Cope with Trauma • Cognitive Emotion Regulation Questionnaire • Mindful Attention Awareness Scale • Modified Medical Outcomes Study Social Support Survey • ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Resilience Scale • Illness Perception Questionnaire • Mini-Mental Adjustment to Cancer Scale • Cancer Behaviour Inventory • Family Resilience Questionnaire • MOS Adherence to Medical Advice Scale • Post-Traumatic Growth Inventory • EORTC Quality of Life questionnaire – General and Breast Cancer module • Fear of Recurrence short form • Hospital Anxiety and Depression Scale • Positive and Negative Affect short form • NCCN Distress Thermometer In addition, one-item questions on relevant psychological constructs have been developed for the purposes of the study. Socio-demographic and lifestyle variables will also be collected, particularly in reference to: • Age • Highest level of education • Marital status • Number of children • Employment status • Income • Absence from work • Smoking and alcohol/drugs consumption • Weight and height • Diet • Exercise • Number of counselling/support sessions • Number of visits with physician/nurse/social worker Questions related to sociodemographic variables will also be embedded in Noona. The following clinical variables will be retrieved from Personal Health Records: • TNM stage • ICD-10 Classification • Tumor biology • Surgery type and side • Previous/ongoing oncological therapy • Side effects due to therapy • Menopausal status • Family history of cancer • Psychotropic medication • Disease-free survival • Basic laboratory tests (blood cell counts, CRP) • Patient pathway data • Biomarkers There will be seven assessment waves, over an 18-month period: baseline, which will occur after the first visit with the oncologist, Month 3 (M3), Month 6 (M6), Month 9 (M9), Month 12 (M12), Month 15 (M15), and Month 18 (M18). During the baseline measurement wave, which will occur within three to four weeks from diagnosis, only non-cancer-specific measures will be delivered (such as personality). Canc...